Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: TECHNOLOGY HOLDING LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-02-27 to 2025-07-26
Current total value of award: $1099025.87
Description: DHA PHASE II SBIR FOR PROJECT TITLED DEVELOPMENT OF HUMAN MONOCLONAL ANTIBODY THERAPEUTIC AGAINST KLEBSIELLA PNEUMONIAE INFECTION